China SXT Pharmaceuticals Inc
SXTC
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.99M
Close$
$6.88
167.8% upside
Current Fair Value
167.8% upsideUndervalued by 167.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.99 Million |
|---|---|
| Enterprise Value | $-16,872,219.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.18 |
| Beta | 1.89 |
| Outstanding Shares | 2,442,684 |
Return
| Return on Equity | -16.33% |
|---|---|
| Return on Assets | -12.54% |
| Return on Invested Capital | -13.14% |
Valuation & Multiples
| P/E Ratio | -2.51 |
|---|---|
| PEG | 1.82 |
| Price to Sales | - |
| Price to Book Ratio | 0.32 |
| Enterprise Value to Revenue | -9.69 |
| Enterprise Value to EBIT | 6.29 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | -0.14 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 19.35%▲ 19.35% |
|---|---|
| Total Invested | $131,330 |
| Investors Holding | 3▲ 3.00% |
ESG Score
No data